Prime Medicine Inc. (PRME) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Prime Medicine Inc.

    NASDAQ: PRME · Real-Time Price · USD
    5.12
    -0.10 (-1.92%)
    At close: Sep 26, 2025, 3:59 PM
    5.11
    -0.20%
    After-hours: Sep 26, 2025, 07:52 PM EDT

    Prime Medicine Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.77 -4.07 -14.83 -6.03
    PEG Ratio
    		 0.07 -0.08 0.35 -0.00
    PS Ratio
    		 116.10 n/a n/a n/a
    PB Ratio
    		 2.26 6.06 5.71 4.16
    P/FCF Ratio
    		 -2.66 -4.63 -12.21 -26.09
    P/OCF Ratio
    		 -2.82 -4.87 -13.7 -29.27
    OCF/S Ratio
    		 -41.19 n/a n/a n/a
    Debt / Equity Ratio
    		 0.27 0.10 0.09 0.04
    Quick Ratio
    		 5.58 2.53 11.10 4.67
    Current Ratio
    		 5.58 2.53 11.10 4.67
    Asset Turnover
    		 0.01 n/a n/a n/a
    Interest Coverage
    		 n/a n/a -9.61 n/a
    Return on Equity
    		 -1.28 -1.49 -0.39 -0.69
    Return on Assets
    		 -0.66 -1.02 -0.34 -0.55
    Return on Invested Capital
    		 -0.76 -1.22 -0.32 -0.33
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 n/a n/a n/a
    Net Profit Margin
    		 -65.67 n/a n/a n/a
    Pretax Profit Margin
    		 -65.67 n/a n/a n/a
    Operating Profit Margin
    		 -67.87 n/a n/a n/a
    FCF Margin
    		 -43.63 n/a n/a n/a
    EBITDA Margin
    		 -65.82 n/a n/a n/a

    Add to Watchlist